- Q1 2024 Bioatla Inc Earnings Call TranscriptMay 14, 2024$2.61 (-1.14%)Earnings
- Q4 2023 Bioatla Inc Earnings Call TranscriptMar 26, 2024$3.01 (+29.18%)Earnings
- Bioatla Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Bioatla Inc R&D Day TranscriptDec 13, 2023
- Q3 2023 Bioatla Inc Earnings Call TranscriptNov 07, 2023$1.76 (-4.35%)Earnings
- Bioatla Inc at HC Wainwright Investment Conference - New York(Pre Recorded) TranscriptSep 11, 2023
- Bioatla Inc at HC Wainwright Immune Cell Engager Virtual Conference TranscriptAug 17, 2023
- Q2 2023 Bioatla Inc Earnings Call TranscriptAug 01, 2023$2.88 (-3.68%)Earnings
- Bioatla Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Bioatla Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Bioatla Inc Earnings Call TranscriptMay 11, 2023$3.21 (-3.02%)Earnings
- Q4 2022 Bioatla Inc Earnings Call TranscriptMar 23, 2023$2.3 (-1.71%)Earnings
- Q3 2022 Bioatla Inc Earnings Call TranscriptNov 03, 2022$6.36 (-1.40%)Earnings
- Q2 2022 Bioatla Inc Earnings Call TranscriptAug 09, 2022$3.61 (-3.48%)Earnings
- Q1 2022 Bioatla Inc Earnings Call TranscriptMay 04, 2022$4.08 (+6.53%)Earnings
Bioatla Inc at HC Wainwright Investment Conference - New York(Pre Recorded) Transcript
Greetings everyone and thank you for joining the H.C. Wainwright 25th Annual Global Investment Conference. My name is Arthur He, a senior biotech analyst with the firm. It's my great pleasure to have Dr. Jay Short, the Chairman, CEO, and Co-Founder of BioAtla joining us for a fireside chat.
BioAtla is a clinical-stage biopharmaceutical company, developing novel therapies for solid tumors based on its proprietary conditionally active biologics platform. The company currently has four drugs in clinic and multiple preclinical candidates across different modalities. To discuss the company's CAB technology and its development strategy in 2023 and beyond, I welcome Jay, to this fireside chat.
Good day, Jay.
Pleasure to be here. Thank you, Arthur.
I'm so glad to see you accepting our invitation to talk to our audience today. So, first place, to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)